Expert slides from CCO on CAR T-cells: optimizing patients for therapy, toxicity management, patient education, promising investigational strategies.
In this commentary, experts answer questions from a recent Clinical Care Options symposium on CAR T-cell therapy
Matthew J. Frigault, MD: Latest data and clinical experience supporting CAR T-cells in real-world patients with CNS disease, HIV, other comorbidities.
Downloadable slides with key data from 2020 ASCO GU created by Clinical Care Options (CCO)
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.